XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Operating activities      
Net income (loss) $ (191,467) $ (266,090) $ 242,350
Adjustments to reconcile to cash from operating activities:      
Depreciation, depletion and amortization 32,630 94,105 82,122
Accretion on asset retirement obligations 4,947 14,939 15,411
Deferred income taxes   14,227 13,680
Employee stock-based compensation expense   13,907 17,305
Amortization relating to financing activities   3,189 2,757
Gain on property insurance recovery related to Mountain Laurel longwall   (23,518)  
Gains on disposals and divestitures, net   (3,460) (818)
Asset impairment 163,088 163,088  
Preference Rights Lease Application settlement income   (23,518) (39,000)
Changes in:      
Receivables   47,416 (4,622)
Inventories   (12,499) (46,073)
Accounts payable, accrued expenses and other current liabilities   (50,474) 1,569
Income taxes, net   22,855 32,440
Other   38,229 16,932
Cash provided by operating activities   55,914 334,053
Investing activities      
Capital expenditures (57,100) (205,661) (137,396)
Minimum royalty payments   (1,186) (1,187)
Proceeds from disposals and divestitures   856 1,799
Purchases of short term investments   (76,593) (158,578)
Proceeds from sales of short term investments   148,670 146,170
Investments in and advances to affiliates, net   (1,549) (4,810)
Proceeds from property insurance recovery related to Mountain Laurel longwall   23,518  
Cash used in investing activities   (111,945) (154,002)
Financing activities      
Payments on term loan due 2024   (2,250) (2,250)
Proceeds from equipment financing   53,611  
Proceeds from tax exempt bonds   53,090  
Net payments on other debt   (19,347) (12,077)
Debt financing costs   (3,528)  
Dividends paid   (7,645) (22,264)
Purchases of treasury stock     (232,999)
Payments for taxes related to net share settlement of equity awards   (346)  
Other     30
Cash provided by (used in) financing activities   73,585 (269,560)
Increase (decrease) in cash and cash equivalents, including restricted cash   17,554 (89,509)
Cash and cash equivalents, including restricted cash, beginning of period 153,020   264,937
Cash and cash equivalents, including restricted cash, end of period 170,574 170,574 175,428
Cash and cash equivalents, including restricted cash, end of period      
Cash and cash equivalents, including restricted cash $ 170,574 $ 170,574 $ 175,428